Cargill, Inc. and Branhaven LLC, today announced a non-exclusive agreement to license BeefTek, Inc., their patented BeefGen genomics (DNA) tools that are intended to help beef and dairy cattle producers analyze bovine genetics to improve meat and milk production. Specific terms of the license agreement were not disclosed.
Cargill stated that the “BeefGen” patented diagnostics are based on molecular tools that may be of use in to improving beef cattle carcass quality and production efficiency. Cargill believes that for beef cattle producers, these genetic tools help identify animals best suited to optimize weight gain, beef marbling, tenderness, red meat yield, rib eye quality and other important characteristics that could increase the value and yield from each animal harvested. Further, Cargill stated that it believes this technology may also assist in identifying genetically superior animals for breeding purposes, which in turn could produce higher quality calves.
BeefTek, Inc. utilizes a proprietary integrated cattle selection, management and marketing program to develop consistently uniform beef production.
Branhaven LLC acquired MetaMorphix, Incorporated’s interests in the assets resulting from the joint development effort with Cargill on this technology (pursuant to MetaMorphix’s bankruptcy proceedings). Branhaven, LLC is a private holding company focused on acquiring companies with strong intellectual properties by leverage its strategic resources to achieve operational improvement; accelerate growth through strategic repositioning of assets and realize scale benefits through add-on acquisitions with joint venture partners.